AFIB Program Page

Presented By

Peter Kudenchuk PhotoPeter J. Kudenchuk, MD
Professor of Medicine
Division of Cardiology
University of Washington
Dr. Kudenchuk is a UW professor of medicine in the Department of Medicine's Division of Cardiology, Arrhythmia Services. His interests include sudden cardiac arrest and cardiac resuscitation, the management of atrial fibrillation, implantable devices such as pacemakers and defibrillators, and the clinical management of cardiac arrhythmias.

Accreditations

Physician Statement
The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for Physicians.
FCM designates each of these educational activities for a maximum of .25  AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of the participation in the activity.
ABIM MOC LogoSuccessful completion of this CME activity enables the participant to earn up to .25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. FCM will submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Statement
The Foundation for Care Management is an approved provider of continuing nursing education by the Washington State Nurses Association Continuing Education Approval & Recognition Program (CEARP), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Pharmacy Statement
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
* This CE activity is knowledge-based.
MS Artwork
Incorporating the Newest Therapies for Anticoagulation in NonValvular AF:
What the Primary Care Provider Needs To Know
This program provides the knowledge and skills to primary care providers (PCPs) interested in the treatment and management of patients at risk for stroke and working as a team for better patient outcomes. Five case study discussions are presented as 15 to 20 minute stand-alone, interactive, voice-over slides courses. Two toolkits are available for download, one for the PCP and one for the patient.

Patient & Professional Toolboxes:   PCP Tookit (PDF File)     Patient Toolkit (PDF File) (Links will open in new window)

Case OnePart 1: A-Fib and Stroke Risk
This segment defines and characterizes nonvalvular atrial fibrillation, its epidemiology, pathophysiology, factors contributing to its increasing prevalence, and how it contributes to thromboembolic and other health risks, especially among high-risk populations.
To Begin Select Your Profession (To view you must be registered and/or logged in)
Case OnePart 2: Pharmacologic and Non-pharmacologic Treatments for AF
This segment describes the effectiveness and limitations of pharmacologic and non-pharmacologic approaches to rhythm management, anticoagulant therapies (including the new target-specific oral anticoagulants) and left atrial occlusion for stroke prevention in patients with nonvalvular atrial fibrillation.
To Begin Select Your Profession (To view you must be registered and/or logged in)
Case OnePart 3: Anticoagulation Therapy for Stroke Prevention
This segment describes the mechanisms of traditional and new direct oral anticoagulant medications, the clinical trials that have established their effectiveness, and some of the precautions required in their use.
To Begin Select Your Profession (To view you must be registered and/or logged in)
Case OnePart 4: Selecting the Right Patient for the Right Therapy
This segment identifies the various diagnostic modalities, including the CHA2DS2-VASc stroke prediction index to identify patients who are suitable candidates for anticoagulation therapy.
To Begin Select Your Profession (To view you must be registered and/or logged in)
Case OnePart 5: Managing Complications of Anticoagulation Therapy
This segment provides information about bleeding complications related to use of anticoagulant medications, approaches to the management of minor, moderate and severe bleeding in such patients, and the development of antidote therapies. It also addresses how to transition patients between different anticoagulation agents while minimizing stroke and bleeding risk, and an overall strategy of follow-up of patients taking anticoagulant drugs.
To Begin Select Your Profession (To view you must be registered and/or logged in)